Sofosvel (velpatasvir)

This topic has 92 replies, 25 voices, and was last updated 7 years, 11 months ago by vitrus.

Viewing 15 posts - 1 through 15 (of 93 total)

1 2 3 … 5 6 7 →

Author

Posts
27 July 2016 at 3:35 pm #21478
tweakmax
- Topics: 18
- Replies: 238
- Total: 256
- Guardian Angel
@tweakmax
https://www.google.com.sg/url?sa=t&source=web&rct=j&url=http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-gilead-faces-competition-from-bangladeshs-beacon-pharma/articleshow/53407488.cms&ved=0ahUKEwiro7TAxpPOAhVKpo8KHQ7TCq4QFggmMAI&usg=AFQjCNGvz4Z54KAtrfRrbc0JAYXtpgjnbg

Yahoo!!!!!
27 July 2016 at 5:37 pm #21485
coral
- Topics: 8
- Replies: 598
- Total: 606
- Guardian Angel
@coral
I’ll second that Yahoo Tweakmax. Way to go Beacon Pharma!
27 July 2016 at 7:09 pm #21488
fitz
- Topics: 9
- Replies: 490
- Total: 499
- Guardian Angel
@fitz
This is fantastic news! Hats off to Beacon!!!
27 July 2016 at 11:20 pm #21494
beahavan
- Topics: 5
- Replies: 81
- Total: 86
- Guardian Angel
@beahavan
I tried to go to the main company website and it said that the account was suspended and to contact my hosting provider.
http://www.beacon-pharma.com

G4
F0-F1
diagnosed in 2006
Tx naive
Treatment started 8/12/16, Ledipasvir/ Sofosbuvir (Harvoni) supplied by Monkmed
8/1/16 ALT 36 AST 40
1/4/17 ALT 17 AST 21
7/13/17 ALT 17 AST 25
12/28/17 ALT 22 AST26
2/22/18 ALT 19 AST 25
7/10/18 ALT 26 AST 32
1/8/19 ALT 16 AST 28
7/2/19 ALT 16 AST 26
Hcv Rna, Quantitative Real Time Pcr <15 NOT DETECTED (IU/mL) NOT DETECTED
27 July 2016 at 11:29 pm #21497
rohcvfighter
- Topics: 50
- Replies: 338
- Total: 388
- Guardian Angel
@rohcvfighter
Hi Beahaven,

same remark from my side, I believe in between the webpage changed and it needs to be updated also on this forum.
See my post from some minutes ago.

Cheers,
RHF

In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google ‚Äúmedicamente generice pentru hepatita C‚Äù.
HCV kills more than 500000 people every year. HCV generic drugs work. Don’t become a statistic.
By sharing this Youtube video you might save someone‚Äôs life!
My TX: HEPCVIR-L[generic Harvoni]-India
SVR52 achieved
28 July 2016 at 12:06 am #21499
MonkMed
- Topics: 1
- Replies: 29
- Total: 30
- Treatment Warrior
@monkmed
UPDATE: July 27th 2016

As per the current timelines GILEAD Licensed Velpatasvir will be available in early September 2016 in India. Epclusa( GILEAD Velpatasvir) is already licensed to Gilead’s 11 Indian manufacturing partners which includes top brands like Mylan,Cipla & Natco which have undergone a complete transfer of technology(TOT). https://en.wikipedia.org/wiki/Technology_transfer.

Licensing does not mean just a business aspect of royalty sharing but more importantly ensuring the quality of the licensed product is exactly same as that of the original pill. This aspect is ensured by rigorous TOT which is explained below.

A complete technology of transfer(TOT) means the process of manufacturing of the pills is exact same as of the original GILEAD pill not just limited to the API but aspects of Excipient which is the NON API materials that goes into the manufacturing https://en.wikipedia.org/wiki/Excipient.

On top of the above, premium companies like Cipla and Mylan have their own Quality assurance processes. So even if pills are manufactured by Hetero and Hetero has its own Quality Assurance and Testing of the pills, after they hand over the pills Cipla and Mylan have their own comprehensive Quality Assurance and Testing process . We like this aspect of double testing which is the precise reason doctors world over trust Cipla and Mylan.

Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.https://en.wikipedia.org/wiki/Mylan.

On top of all the above all Indian manufacturing units that manufacture or sell Licensed products are US FDA certified and have to keep up with rigorous standards also called Current Good Manufacturing Practices (CGMPs)

http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/ucm169105.htm

Currently DCGI (Drug Controller General of India) approval for generic Velpatasvir is in process as the 11 Indian companies are gearing up production for early September launch.
28 July 2016 at 2:02 am #21508
Gaj
- Topics: 29
- Replies: 1,402
- Total: 1,431
- Guardian Angel
@gaj
rohcvfighter wrote:

Hi Beahaven,

same remark from my side, I believe in between the webpage changed and it needs to be updated also on this forum.
See my post from some minutes ago.

Cheers,
RHF

Beacon’s Pharmas Market page has been updated to their new web address: http://www.beaconpharma.com.bd

G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
28 July 2016 at 3:12 am #21511
Greedfighter
- Topics: 28
- Replies: 582
- Total: 610
- Guardian Angel
@greedfighter
Ha ha, that didn’t take long 3 cheers for Bangladesh (exempt from pharmaceutical patents until 2033)

I’m sure Gilead are thrilled!

Home

Already taking orders
28 July 2016 at 5:23 am #21513
splitdog
- Topics: 5
- Replies: 374
- Total: 379
- Guardian Angel
@splitdog
splitdog@roadrunner.com

Genotype 3
VL 4,100,000
ALT 101 AST 71
Treatment Naive
Started Sof/Dac Jan 12, 2016
VL= <15 4 weeks in. AST/ALT normal.
VL=UNDETECTED 8 weeks in.
SVR4= Virus back. 3,300,000

Started generic Epclusa Sep. 23, 2017

4 weeks in <15 *Detected.
12 weeks in <15 *Not Detected.
16 weeks in <15 *Not Detected.
Finished 24 weeks treatment 3-17-18
SVR5 <15 Not Detected.
SVR 20 <15 Not Detected.
SVR 44 <15 Not Detected.

Thank you Jesus.
Thank you Dr. James
28 July 2016 at 11:06 am #21532
Dr James
- Topics: 264
- Replies: 1,968
- Total: 2,232
- Guardian Angel
@fixhepc
Left to right: Md Monjur Alam, Md. Ebadul Karim (Managing Director), Dr James Freeman, Prof. Dr. Syed Modasser Ali (Chaiman of BMRC), and Mr James Cheng

YMMV
28 July 2016 at 11:27 am #21537
beaconbdd
- Topics: 0
- Replies: 29
- Total: 29
- Treatment Warrior
@beaconbdd
Sofosvel is the 3rd product we launched as first global generic from beacon pharmaceuticals Ltd. Today is the world hepatitis day and launching of the Sofosvel (sofosbuvir + velpatasvir) is the great news for all hep c patients. They can get right treatment at affordable price. Our earlier two global first generic products were Tagrix (osimertinib) for lung cancer & Darvoni (sofosbuvir + daclatasvir) for all genotypes of hepatitis patients.
Attachments:
28 July 2016 at 11:34 am #21540
beaconbdd
- Topics: 0
- Replies: 29
- Total: 29
- Treatment Warrior
@beaconbdd
Sofosvel
Attachments:
28 July 2016 at 12:16 pm #21541
Gaj
- Topics: 29
- Replies: 1,402
- Total: 1,431
- Guardian Angel
@gaj
Pharma’s Market updated.

G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
28 July 2016 at 4:33 pm #21543
fitz
- Topics: 9
- Replies: 490
- Total: 499
- Guardian Angel
@fitz
Outstanding!

Some people just talk about doing things. Others make them happen.

Thank you Beacon, and Dr James Freeman!

Also, whoever did the branding/graphics is brilliant. GREAT professional branding!
29 July 2016 at 4:53 pm #21622
fitz
- Topics: 9
- Replies: 490
- Total: 499
- Guardian Angel
@fitz
Not replying to my own post. Just giving this a ‘bump’ because it is literally the biggest and best news on generic treatment options in the whole world right now – and needs to stay at or near the top of the ‘Recent Topics’ section.
Author

Posts